<p>Disclosed is (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride effective as a vascular disrupting agent. (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride is useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs, and in particular to its use in treating cancer.</p>
申请公布号
EP2144888(A1)
申请公布日期
2010.01.20
申请号
EP20080745508
申请日期
2008.04.10
申请人
MYRIAD PHARMACEUTICALS, INC.
发明人
LAUGHLIN, MARK;ANDERSON, MARK, B.;WILLARDSEN, ADAM;PLEIMAN, CHRIS